R. Bell

Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy.

B. Fox, A. Weinberg, B. Curti, 2016, Oral oncology.

OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer

B. Fox, R. Bell, A. Weinberg, 2016, Clinical & translational immunology.

OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironment.

B. Fox, R. Bell, W. Urba, 2016, Oral oncology.

Immunotherapy in Head and Neck Cancers

B. Fox, R. Bell, C. Bifulco, 2016 .

Multiparametric immune profiling in HPV- oral squamous cell cancer.

Tuan Bui, Carmen Ballesteros-Merino, Clifford Hoyt, 2017, JCI insight.

Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma.

T. D. de Gruijl, R. Leidner, M. Crittenden, 2018, Cancer research.

FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment

C. Bifulco, J. Ravetch, S. Jensen, 2023, Cancer immunology research.